These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 29665366)

  • 1. 3,7-Bis(2-hydroxyethyl)icaritin, a potent inhibitor of phosphodiesterase-5, prevents monocrotaline-induced pulmonary arterial hypertension via NO/cGMP activation in rats.
    Lan TH; Chen XL; Wu YS; Qiu HL; Li JZ; Ruan XM; Xu DP; Lin DQ
    Eur J Pharmacol; 2018 Jun; 829():102-111. PubMed ID: 29665366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrandrine prevents monocrotaline-induced pulmonary arterial hypertension in rats through regulation of the protein expression of inducible nitric oxide synthase and cyclic guanosine monophosphate-dependent protein kinase type 1.
    Wang X; Yang Y; Yang D; Tong G; Lv S; Lin X; Chen C; Dong W
    J Vasc Surg; 2016 Nov; 64(5):1468-1477. PubMed ID: 26527422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CPU 86017, p-chlorobenzyltetrahydroberberine chloride, attenuates monocrotaline-induced pulmonary hypertension by suppressing endothelin pathway.
    Zhang TT; Cui B; Dai DZ; Su W
    Acta Pharmacol Sin; 2005 Nov; 26(11):1309-16. PubMed ID: 16225752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel peptide for attenuation of hypoxia-induced pulmonary hypertension via modulation of nitric oxide release and phosphodiesterase -5 activity.
    Hu H; Zharikov S; Patel JM
    Peptides; 2012 May; 35(1):78-85. PubMed ID: 22465621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liraglutide prevents and reverses monocrotaline-induced pulmonary arterial hypertension by suppressing ET-1 and enhancing eNOS/sGC/PKG pathways.
    Lee MY; Tsai KB; Hsu JH; Shin SJ; Wu JR; Yeh JL
    Sci Rep; 2016 Sep; 6():31788. PubMed ID: 27581840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
    Liu CP; Dai ZK; Huang CH; Yeh JL; Wu BN; Wu JR; Chen IJ
    Kaohsiung J Med Sci; 2014 Jun; 30(6):267-78. PubMed ID: 24835346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation.
    Zhai C; Shi W; Feng W; Zhu Y; Wang J; Li S; Yan X; Wang Q; Zhang Q; Chai L; Li C; Liu P; Li M
    Life Sci; 2018 Sep; 208():87-95. PubMed ID: 30009823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme 2 activation ameliorates pulmonary endothelial dysfunction in rats with pulmonary arterial hypertension through mediating phosphorylation of endothelial nitric oxide synthase.
    Li G; Zhang H; Zhao L; Zhang Y; Yan D; Liu Y
    J Am Soc Hypertens; 2017 Dec; 11(12):842-852. PubMed ID: 29146157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
    Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
    Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive and remedial application of etanercept attenuate monocrotaline-induced pulmonary arterial hypertension.
    Zhang LL; Lu J; Li MT; Wang Q; Zeng XF
    Int J Rheum Dis; 2016 Feb; 19(2):192-8. PubMed ID: 24612527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tadalafil, a long-acting inhibitor of PDE5, improves pulmonary hemodynamics and survival rate of monocrotaline-induced pulmonary artery hypertension in rats.
    Sawamura F; Kato M; Fujita K; Nakazawa T; Beardsworth A
    J Pharmacol Sci; 2009 Nov; 111(3):235-43. PubMed ID: 19881228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genistein attenuates monocrotaline-induced pulmonary arterial hypertension in rats by activating PI3K/Akt/eNOS signaling.
    Zheng Z; Yu S; Zhang W; Peng Y; Pu M; Kang T; Zeng J; Yu Y; Li G
    Histol Histopathol; 2017 Jan; 32(1):35-41. PubMed ID: 27087006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing the ERK/MAPK pathway.
    Gao H; Cheng Y; Zong L; Huang L; Qiao C; Li W; Gong B; Hu J; Liu H; Wang X; Zhao C
    Clin Exp Hypertens; 2017; 39(1):34-41. PubMed ID: 28055284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme inhibitor preserves p21 and endothelial nitric oxide synthase expression in monocrotaline-induced pulmonary arterial hypertension in rats.
    Kanno S; Wu YJ; Lee PC; Billiar TR; Ho C
    Circulation; 2001 Aug; 104(8):945-50. PubMed ID: 11514384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of aerobic exercise training on metabolism of nitric oxide and endothelin-1 in lung parenchyma of rats with pulmonary arterial hypertension.
    Zimmer A; Teixeira RB; Bonetto JH; Siqueira R; Carraro CC; Donatti LM; Hickmann A; Litvin IE; Godoy AE; Araujo AS; Colombo R; Belló-Klein A
    Mol Cell Biochem; 2017 May; 429(1-2):73-89. PubMed ID: 28181133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension.
    Schaffner D; Lazaro A; Deibert P; Hasselblatt P; Stoll P; Fauth L; Baumstark MW; Merfort I; Schmitt-Graeff A; Kreisel W
    World J Gastroenterol; 2018 Oct; 24(38):4356-4368. PubMed ID: 30344420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.
    Zhuang W; Lian G; Huang B; Du A; Xiao G; Gong J; Xu C; Wang H; Xie L
    Exp Biol Med (Maywood); 2018 Aug; 243(12):995-1003. PubMed ID: 30099957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amlodipine prevents monocrotaline-induced pulmonary arterial hypertension and prolongs survival in rats independent of blood pressure lowering.
    Mawatari E; Hongo M; Sakai A; Terasawa F; Takahashi M; Yazaki Y; Kinoshita O; Ikeda U
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):594-600. PubMed ID: 17581214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrahydrobiopterin (BH
    Francis BN; Salameh M; Khamisy-Farah R; Farah R
    Cardiovasc Ther; 2018 Feb; 36(1):. PubMed ID: 29151278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.